Transplantation, Tumor, Autoimmune disease
Conditions
Interventions
Group A:Take the dietary supplement methionine (40 mg/kg/day, orally) daily for 4 weeks in addition to your normal diet
Group B:Take the dietary supplement methionine (80 mg/kg/day, orally) daily for 4 weeks in addition to your normal diet
Group C:Eat a normal diet with no additional nutritional supplementation for 4 weeks
Sponsors
Tianjin First Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1.Healthy male or female, aged 18 to 55 years inclusive. 2.Fully informed about the content, procedures, and potential adverse reactions of the trial. 3.Capable of effective communication with the researchers and able to understand and comply with all requirements of this study. 4.At the time of screening, all trial-related examinations show no clinically significant abnormalities, as determined by the clinical research physician.
Exclusion criteria
Exclusion criteria: 1.Dysphagia. 2.Pregnant or breastfeeding women. 3.Individuals who may be unable to complete the study for other reasons, or who are deemed by the investigator to have other reasons that make them unsuitable for participation in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number and function of immune cells in blood samples; | — |
Secondary
| Measure | Time frame |
|---|---|
| Metabolite alterations in subjects; | — |
Countries
China
Contacts
Public ContactZhongyang Shen
Tianjin First Central Hospital
Outcome results
None listed